All these results demonstrate for the first time the possible mechanism by which an oxidant agent activate AChE in human neuroblastoma cells, and makes aware of the importance of studying the impact of antioxidant agents treatment as a suitable strategy to decrease ROS levels and consequently to block AChE activity and isoform profile alterations. Here, ACHE is linked to neuroblastoma.